Table 1 Demographic profile of patients involved in the study (n = 103)
| Â | n (%) |
|---|---|
Age (years) | 56.34 ± 9.79 |
Menopausal status | |
 Pre menopausal | 19 (18.4) |
 Post menopausal | 84 (81.6) |
Histological type | |
 Endometrioid | 87 (84.5) |
 Serous | 9 (8.7) |
 Clear cell | 1 (1) |
 Carcinosarcoma | 6 (5.8) |
Grade | |
 Grade I | 41 (39.8) |
 Grade II | 40 (38.8) |
 Grade III | 22 (21.4) |
Myometrial invasion | |
 Limited to endometrium | 6 (5.8) |
 Less than half of myometrium | 38 (36.9) |
 More than half of myometrium | 59 (57.3) |
Cervical invasion | |
 Present | 26 (25.2) |
 Absent | 77 (74.8) |
Adnexal involvement | |
 Present | 11 (10.7) |
 Absent | 92 (89.3) |
Nodal status | |
 N0 | 96 (93.2) |
 N1 | 6 (5.8) |
 N2 | 1 (1) |
Lymphovascular invasion | |
 Present | 8 (7.8) |
 Absent | 95 (92.2) |
T stage | |
 T1 | 72 (69.9) |
 T2 | 17 (16.5) |
 T3 | 10 (9.7) |
 T4 | 4 (3.9) |
FIGO stage | |
 Stage IA | 40 (38.8) |
 Stage IB | 31 (30.1) |
 Stage II | 18 (17.5) |
 Stage IIIA | 8 (7.8) |
 Stage IIIB | 2 (1.9) |
 Stage IV | 4 (3.9) |